Stephens & Co. Reiterates Equal-Weight on CareDx, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Mason Carrico has reiterated an Equal-Weight rating on CareDx (NASDAQ:CDNA) and maintained a $10 price target.
September 26, 2023 | 12:38 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Stephens & Co. has reiterated an Equal-Weight rating on CareDx and maintained a $10 price target.
The news is directly about CareDx and its rating by Stephens & Co. The reiteration of the Equal-Weight rating and the maintenance of the $10 price target suggests that the analyst sees no significant changes in the company's outlook. This is likely to have a neutral impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100